Intermittent Hypoxia Composite Abnormal Glucose Metabolism-Mediated Atherosclerosis In Vitro and In Vivo: The Role of SREBP-1

Figure 6

The level of FBG and serum insulin in the Con group, NC group, and CIH group. (a) FBG at CIH treatment at 4 w, (b) FBG at CIH treatment at 8 w, and (c) serum insulin at CIH treatment at 8 w.

(a)

(b)

(c)